Clinical Trials in Denver

Showing 6741-6760 of 18,161 trials

Expanded Access Program of Surufatinib

NCT04814732

This treatment protocol is intended to provide early access of surufatinib to patients with locally advanced or metastatic NETs for whom, in the opinion of their treating physician, other treatment options or surufatinib clinical trials in this indication are unsuitable. This EAP is currently available in the US only.

Neuroendocrine Tumors

Hutchmed

Denver, Colorado, United States • Baltimore, Maryland, United States • Detroit, Michigan, United States +8 more locations

COMPLETEDPhase 26.3 miles

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

NCT04305275

This is a phase 2, double-blind, placebo-controlled study to evaluate the safety and efficacy of SAGE-324 compared to placebo on upper limb (UL) tremor reduction in individuals with essential tremor (ET).

Essential Tremor

Sage Therapeutics69 participantsStarted May 2020

Phoenix, Arizona, United States • Rogers, Arkansas, United States • Fresno, California, United States +24 more locations

Expanded Access Program of Surufatinib

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

Find Trials by Condition in Denver

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Post-Prandial Liver Glucose Metabolism in PCOS

Study Using Negative Pressure to Reduce Apnea

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Letrozole for Lymphangioleiomyomatosis

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

Financial Incentives, Randomization With Stepped Treatment Trial

Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders